The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-04-28
DOI
10.3389/fimmu.2017.00510
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TLR-Stimulated Neutrophils Instruct NK Cells To Trigger Dendritic Cell Maturation and Promote Adaptive T Cell Responses
- (2015) Rebecca E. Riise et al. JOURNAL OF IMMUNOLOGY
- B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape
- (2015) Silvia Pesce et al. OncoImmunology
- Natural Killer Cells Induce Eosinophil Activation and Apoptosis
- (2014) Ali Awad et al. PLoS One
- Human NK cell response to pathogens
- (2014) Mariella Della Chiesa et al. SEMINARS IN IMMUNOLOGY
- Enrichment of CD56dimKIR+CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients
- (2014) Talib Hassan Ali et al. Nature Communications
- Eosinophils and Cancer
- (2014) B. P. Davis et al. Cancer Immunology Research
- Induction of B7-H6, a ligand for the natural killer cell-activating receptor NKp30, in inflammatory conditions
- (2013) J. Matta et al. BLOOD
- KIR2DS1-dependent acquisition of CCR7 and migratory properties by human NK cells interacting with allogeneic HLA-C2+ DCs or T-cell blasts
- (2013) E. Marcenaro et al. BLOOD
- Identification of a cellular ligand for the natural cytotoxicity receptor NKp44
- (2013) F. Baychelier et al. BLOOD
- Lipoxin A4 Regulates Natural Killer Cell and Type 2 Innate Lymphoid Cell Activation in Asthma
- (2013) C. Barnig et al. Science Translational Medicine
- The expanding role(s) of eosinophils in health and disease
- (2012) E. A. Jacobsen et al. BLOOD
- Involvement of eosinophils in the anti-tumor response
- (2012) Solène Gatault et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Novel cooperation between CX3CL1 and CCL26 inducing NK cell chemotaxis via CX3CR1: a possible mechanism for NK cell infiltration of the allergic nasal tissue
- (2012) A. E. El-Shazly et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Pattern-recognition receptors in human eosinophils
- (2012) Anne Månsson Kvarnhammar et al. IMMUNOLOGY
- Human NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism
- (2012) F. B. Thoren et al. JOURNAL OF IMMUNOLOGY
- Dendritic Cell Editing by Activated Natural Killer Cells Results in a More Protective Cancer-Specific Immune Response
- (2012) Barbara Morandi et al. PLoS One
- Eosinophils elicit proliferation of naive and fungal-specific cells in vivo so enhancing a T helper type 1 cytokine profile in favour of a protective immune response against Cryptococcus neoformans infection
- (2011) Ana P. Garro et al. IMMUNOLOGY
- NK cells and their receptors during viral infections
- (2011) Emanuela Marcenaro et al. Immunotherapy
- Modulation of NK Cell Autocrine-Induced Eosinophil Chemotaxis by Interleukin-15 and Vitamin D3: A Possible NK-Eosinophil Crosstalk via IL-8 in the Pathophysiology of Allergic Rhinitis
- (2011) A. E. El-Shazly et al. MEDIATORS OF INFLAMMATION
- Innate or Adaptive Immunity? The Example of Natural Killer Cells
- (2011) E. Vivier et al. SCIENCE
- Eosinophils in innate immunity: an evolving story
- (2010) Revital Shamri et al. CELL AND TISSUE RESEARCH
- Eosinophils as antigen-presenting cells in allergic upper airway disease
- (2010) Praveen Akuthota et al. Current Opinion in Allergy and Clinical Immunology
- Eosinophils and Th2 immunity: contemporary insights
- (2010) Lisa A Spencer et al. IMMUNOLOGY AND CELL BIOLOGY
- The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes
- (2010) F. Bellora et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Eosinophil Survival and Apoptosis in Health and Disease
- (2010) Yong Mean Park et al. Allergy Asthma & Immunology Research
- Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction
- (2009) E. Marcenaro et al. BLOOD
- The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans
- (2009) Cameron S. Brandt et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Eosinophils and allergic airway disease: there is more to the story
- (2009) Elizabeth R. Walsh et al. TRENDS IN IMMUNOLOGY
- Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells
- (2008) S. Agaugue et al. BLOOD
- Immunoregulatory roles of eosinophils: a new look at a familiar cell
- (2008) P. Akuthota et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Eosinophils: Biological Properties and Role in Health and Disease
- (2008) SIMON P. HOGAN et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Interferon-γ enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5
- (2008) Takafumi Yamaguchi et al. IMMUNOLOGY LETTERS
- Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC
- (2008) E. Marcenaro et al. INTERNATIONAL IMMUNOLOGY
- Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially
- (2008) L. A. Spencer et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Perturbations of natural killer cell regulatory functions in respiratory allergic diseases
- (2007) Francesca Scordamaglia et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started